Data / Form D filings / Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc.: Form D filings
Adverum Biotechnologies, Inc., a biotechnology company in Redwood City, CA, filed 4 Form D notices with the SEC between 2013 and 2024. The latest, on February 21, 2024, reports $127.8 million sold of a $127.8 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 CARDINAL WAY, Redwood City, CA, 94063
- Phone
- (650) 656-9323
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1501756
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | New notice | $127,800,000 | $127,800,000 | 20 | Feb 7, 2024 | sec.gov | |
| Sep 8, 2014 | New notice | $9,999,995 | $9,999,995 | 1 | Aug 5, 2014 | sec.gov | |
| Apr 28, 2014 | New notice | $55,978,020 | $55,127,152 | $850,868 | 45 | Apr 16, 2014 | sec.gov |
| Nov 26, 2013 | New notice | $6,138,277 | $5,653,890 | $484,387 | 16 | Sep 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| C. David Nicholson | Director | |
| Linda Rubinstein | Executive Officer | |
| Rabia Gurses Ozden | Director | |
| Setareh Gurses Seyedkazemi | Executive Officer | |
| Kishor Peter Soparkar | Executive Officer | |
| Soo Hong | Director | |
| Dawn Gurses Svoronos | Director | |
| James Gurses Scopa | Director | |
| Reed Gurses Tuckson | Director | |
| Mark Lupher | Director | |
| Laurent Fischer | Executive Officer, Director | |
| Patrick Machado | Director | |
| Scott Gurses Whitcup | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 19, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adverum Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.